Opportunistic Infections Citation List:
July 22 - August 4, 2011
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Antifungal Activity of Coriaria nepalensis Essential Oil by Disrupting Ergosterol Biosynthesis and Membrane Integrity Against Candida. Ahmad, A., A. Khan, P. Kumar, R.P. Bhatt, and N. Manzoor. Yeast (Chichester, England), 2011. 28(8): p. 611-617; PMID[21755533].
[Pubmed]. OI_0722-080411.
2. Broad-Spectrum Biofilm Inhibition by Kingella kingae Exopolysaccharide.Bendaoud, M., E. Vinogradov, N.V. Balashova, D.E. Kadouri, S.C. Kachlany, and J.B. Kaplan. Journal of Bacteriology, 2011. 193(15): p. 3879-3886; PMID[21602333].
[Pubmed]. OI_0722-080411.
3. A Novel Assay of Biofilm Antifungal Activity Reveals that Amphotericin B and Caspofungin Lyse Candida albicans Cells in Biofilms. Didone, L., D. Oga, and D.J. Krysan. Yeast (Chichester, England), 2011. 28(8): p. 561-568; PMID[21674619].
[Pubmed]. OI_0722-080411.
4. 7-Chloroquinolin-4-yl Arylhydrazone Derivatives: Synthesis and Antifungal Activity. Duval, A.R., P.H. Carvalho, M.C. Soares, D.P. Gouvea, G.M. Siqueira, R.G. Lund, and W. Cunico. The Scientific World Journal, 2011. 11: p. 1489-1495; PMID[21805018].
[Pubmed]. OI_0722-080411.
5. Antifungal Activity of Coriandrum sativum Essential Oil, its Mode of Action Aainst Candida Secies and Poential Synergism with Amphotericin B. Silva, F., S. Ferreira, A. Duarte, D.I. Mendonca, and F.C. Domingues. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 2011. [Epub ahead of print]; PMID[21788125].
[Pubmed]. OI_0722-080411.
6. Blocking Candida albicans Biofilm Formation by BDSF and trans-BDSF. Zhang, Y., C. Cai, Y. Yang, L. Weng, and L. Wang. Journal of Medical Microbiology, 2011. [Epub ahead of print]; PMID[21778264].
[Pubmed]. OI_0722-080411.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
7. Novel 1,2,3-triazole Derivatives for use Against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strains. Boechat, N., V.F. Ferreira, S.B. Ferreira, M.D. Ferreira, F.D. da Silva, M.M. Bastos, M.D. Costa, M.C. Lourenco, A. Pinto, A.U. Krettli, A.C. Aguiar, B.M. Teixeira, N.V. da Silva, P.R. Martins, F.A. Bezerra, A.L. Camilo, G.P. da Silva, and C.C. Costa. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21776985].
[Pubmed]. OI_0722-080411.
8. Synthesis, Molecular Modeling and Bio-evaluation of Cycloalkyl Fused 2-Aminopyrimidines as Antitubercular and Antidiabetic Agents. Singh, N., S.K. Pandey, N. Anand, R. Dwivedi, S. Singh, S.K. Sinha, V. Chaturvedi, N. Jaiswal, A.K. Srivastava, P. Shah, M.I. Siddiqui, and R.P. Tripathi. Bioorganic & Medicinal Chemistry Letters, 2011. 21(15): p. 4404-4408; PMID[21737274].
[Pubmed]. OI_0722-080411.
9. A Prodrug Approach for Improving Anti-tuberculosis Activity of Potent Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors. Tizon, L., J.M. Otero, V.F. Prazeres, A.L. Llamas-Saiz, G.C. Fox, M.J. van Raaij, H. Lamb, A.R. Hawkins, J.A. Ainsa, L. Castedo, and C. Gonzalez-Bello. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21780742].
[Pubmed]. OI_0722-080411.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
10. New Salicylamide and Sulfonamide Derivatives of Quinoxaline1,4-di-N-oxide with Antileishmanial and Antimalarial Activities. Barea, C., A. Pabon, D. Castillo, M. Zimic, M. Quiliano, S. Galiano, S. Perez-Silanes, A. Monge, E. Deharo, and I. Aldana. Bioorganic & Medicinal Chemistry Letters, 2011. 21(15): p. 4498-4502; PMID[21724395].
[Pubmed]. OI_0722-080411.
11. Design and Evaluation of Primaquine-Artemisinin Hybrids as a Multistage Anti-Malarial Strategy. Capela, R., G.G. Cabal, P.J. Rosenthal, J. Gut, M.M. Mota, R. Moreira, F. Lopes, and M. Prudencio. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21807973].
[Pubmed]. OI_0722-080411.
12. Effects of Highly Active Novel Artemisinin-Chloroquinoline Hybrid Compounds on beta-Hematin Formation, Parasite Morphology and Endocytosis in Plasmodium falciparum. Feng, T.S., E.M. Guantai, M. Nell, C.E. van Rensburg, K. Ncokazi, T.J. Egan, H.C. Hoppe, and K. Chibale. Biochemical Pharmacology, 2011. 82(3): p. 236-247; PMID[21596024].
[Pubmed]. OI_0722-080411.
13. Synthesis and Biological Activities of 4-N-(Anilinyl-n-[oxazolyl])-7-chloroquinolines (n=3' or 4') Against Plasmodium falciparum in In vitro Models. Gordey, E.E., P.N. Yadav, M.P. Merrin, J. Davies, S.A. Ward, G.M. Woodman, A.L. Sadowy, T.G. Smith, and R.A. Gossage. Bioorganic & Medicinal Chemistry Letters, 2011. 21(15): p. 4512-4515; PMID[21723121].
[Pubmed]. OI_0722-080411.
14. Antiplasmodial and Antitrypanosomal Activity of Pyrethrins and Pyrethroids.Hata, Y., S. Zimmermann, M. Quitschau, M. Kaiser, M. Hamburger, and M. Adams. Journal of Agricultural and Food Chemistry, 2011. [Epub ahead of print]; PMID[21786822].
[Pubmed]. OI_0722-080411.
15. Multi-targeted Activity of Maslinic acid as an Antimalarial Natural Compound.Moneriz, C., J. Mestres, J.M. Bautista, A. Diez, and A. Puyet. The FEBS Journal, 2011. 278(16): p. 2951-2961; PMID[21689375].
[Pubmed]. OI_0722-080411.
16. Glutathione Reductase-Catalyzed Cascade of Redox Reactions To Bioactivate Potent Antimalarial 1,4-Naphthoquinones - A New Strategy to Combat Malarial Parasites. Muller, T., L. Johann, B. Jannack, M. Bruckner, D.A. Lanfranchi, H. Bauer, C. Sanchez, V. Yardley, C. Deregnaucourt, J. Schrevel, M. Lanzer, R.H. Schirmer, and E. Davioud-Charvet. Journal of the American Chemical Society, 2011. 133(30): p. 11557-11571; PMID[21682307].
[Pubmed]. OI_0722-080411.
17. In vivo and In vitro Antimalarial Activity of 4-Nerolidylcatechol.Rocha, E.S.L.F., A.C. Silva Pinto, A.M. Pohlit, E.L. Quignard, P.P. Vieira, W.P. Tadei, F.C. Chaves, J.F. Samonek, C.A. Lima, M.R. Costa, M.G. Alecrim, and V.F. Andrade-Neto. Phytotherapy Research: PTR, 2011. 25(8): p. 1181-1188; PMID[21302338].
[Pubmed]. OI_0722-080411.
18. Synthesis and Antimalarial Activity of New Heterocyclic Hybrids Based on Chloroquine and Thiazolidinone Scaffolds. Rojas Ruiz, F.A., R.N. Garcia-Sanchez, S.V. Estupinan, A. Gomez-Barrio, D.F. Torres Amado, B.M. Perez-Solorzano, J.J. Nogal-Ruiz, A.R. Martinez-Fernandez, and V.V. Kouznetsov. Bioorganic & Medicinal Chemistry, 2011. 19(15): p. 4562-4573; PMID[21723734].
[Pubmed]. OI_0722-080411.
19. Antiplasmodial and Cytotoxicity Evaluation of 3-Functionalized 2-Azetidinone Derivatives. Singh, P., S. Sachdeva, R. Raj, V. Kumar, M.P. Mahajan, S. Nasser, L. Vivas, J. Gut, P.J. Rosenthal, T.S. Feng, and K. Chibale. Bioorganic & Medicinal Chemistry Letters, 2011. 21(15): p. 4561-4563; PMID[21705220].
[Pubmed]. OI_0722-080411.
ANTILEISHMANIA COMPOUNDS
20. Studies on the Antileishmanial Properties of the Antimicrobial Peptides Temporin A, B and 1Sa. Chadbourne, F.L., C. Raleigh, H.Z. Ali, P.W. Denny, and S.L. Cobb. Journal of Peptide Science : An Official Publication of the European Peptide Society, 2011. [Epub ahead of print]; PMID[21805542].
[Pubmed]. OI_0722-080411.
21. Antiprotozoal and Antiangiogenic Saponins from Apodytes dimidiata. Foubert, K., F. Cuyckens, A. Matheeussen, A. Vlietinck, S. Apers, L. Maes, and L. Pieters. Phytochemistry, 2011. 72(11-12): p. 1414-1423; PMID[21601896].
[Pubmed]. OI_0722-080411.
22. Selenocyanates and Diselenides: A New Class of Potent Antileishmanial Agents. Plano, D., Y. Baquedano, D. Moreno-Mateos, M. Font, A. Jimenez-Ruiz, J.A. Palop, and C. Sanmartin. European Journal of Medicinal Chemistry, 2011. 46(8): p. 3315-3323; PMID[21571403].
[Pubmed]. OI_0722-080411.
23. Antiparasitic Activity of C-Geranyl Flavonoids from Mimulus bigelovii. Salem, M.M., J. Capers, S. Rito, and K.A. Werbovetz. Phytotherapy Research : PTR, 2011. 25(8): p. 1246-1249; PMID[21796699].
[Pubmed]. OI_0722-080411.
24. Uptake and Antileishmanial Activity of Meglumine Antimoniate-containing Liposomes in Leishmania (Leishmania) Major-infected Macrophages.Treiger Borborema, S.E., R.A. Schwendener, J.A. Osso Junior, H.F. de Andrade Junior, and N. do Nascimento. International Journal of Antimicrobial Agents, 2011. [Epub ahead of print]; PMID[21783345].
[Pubmed]. OI_0722-080411.
Citations from the ISI Web of Knowledge Listings for O.I.
25. Design, Synthesis and Antimycobacterial Evaluation of Novel 3-Substituted-N-Aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno 1,2-c pyrazole -2-carboxamide Analogues. Ahsan, M.J., J.G. Samy, K.R. Dutt, U.K. Agrawal, B.S. Yadav, S. Vyas, R. Kaur, and G. Yadav, Bioorganic & Medicinal Chemistry Letters, 2011. 21(15): p. 4451-4453. ISI[000292729900014].
[WOS]. OI_0722-080411.
26. Microbial Transformation of (+)-Heraclenin by Aspergillus niger and Evaluation of its Antiplasmodial and Antimicrobial Activities. Gowri, P.M., K. Haribabu, H. Kishore, O. Manjusha, S. Biswas, and U.S.N. Murty, Current Science, 2011. 100(11): p. 1706-1711. ISI[000292698100017].
[WOS]. OI_0722-080411.
27. Antifungal Activity of Lariciresinol Derived from Sambucus williamsii and Their Membrane-active Mechanisms in Candida albicans.Hwang, B., J. Cho, I.S. Hwang, H.G. Jin, E.R. Woo, and D.G. Lee, Biochemical and Biophysical Research Communications, 2011. 410(3): p. 489-493. ISI[000292797700021].
[WOS]. OI_0722-080411.
28. Synthesis and Antimicrobial Evaluation of New Benzofuran Derivatives. Jiang, X.Z., W.L. Liu, W. Zhang, F.Q. Jiang, Z. Gao, H. Zhuang, and L. Fu, European Journal of Medicinal Chemistry, 2011. 46(8): p. 3526-3530. ISI[000292670000039].
[WOS]. OI_0722-080411.
29. Synthesis, In vitro Evaluation and Molecular Docking Studies of New Triazole Derivatives as Antifungal Agents. Jiang, Y.W., J. Zhang, Y.B. Cao, X.Y. Chai, Y. Zou, Q.Y. Wu, D.Z. Zhang, Y.Y. Jiang, and Q.Y. Sun, Bioorganic & Medicinal Chemistry Letters, 2011. 21(15): p. 4471-4475. ISI[000292729900019].
[WOS]. OI_0722-080411.
30. Chemical Composition and Antimicrobial Activity of the Essential Oil of Rosemary. Jiang, Y., N. Wu, Y.J. Fu, W. Wang, M. Luo, C.J. Zhao, Y.G. Zu, and X.L. Liu, Environmental Toxicology and Pharmacology, 2011. 32(1): p. 63-68. ISI[000292484100001].
[WOS]. OI_0722-080411.
31. Assessment of Antimicrobial Activity of Catechu and Its Dyed Substrate. Khan, M.I., A. Ahmad, S.A. Khan, M. Yusuf, M. Shahid, N. Manzoor, and F. Mohammad, Journal of Cleaner Production, 2011. 19(12): p. 1385-1394. ISI[000292716800013].
[WOS]. OI_0722-080411.
32. Effective Inhibitors of the Essential Kinase PknB and Their Potential as anti-Mycobacterial Agents. Lougheed, K.E.A., S.A. Osborne, B. Saxty, D. Whalley, T. Chapman, N. Bouloc, J. Chugh, T.J. Nott, D. Patel, V.L. Spivey, C.A. Kettleborough, J.S. Bryans, D.L. Taylor, S.J. Smerdon, and R.S. Buxton, Tuberculosis, 2011. 91(4): p. 277-286. ISI[000292631900001].
[WOS]. OI_0722-080411.
33. Study on Chemical Composition and Biological Activities of Essential Oil and Extracts from Stevia rebaudiana Bertoni Leaves.Muanda, F.N., R. Soulimani, B. Diop, and A. Dicko, Lwt-Food Science and Technology, 2011. 44(9): p. 1865-1872. ISI[000292792400005].
[WOS]. OI_0722-080411.
34. Studies on Microbial Activity and Dyeing Performance of Novel Acid Azo Dyes Based on 3-(4-Aminophenyl)-2-phenylquinazolin-4(3h)-one.Parekh, N., K. Maheria, and P. Patel, Journal of Scientific & Industrial Research, 2011. 70(7): p. 525-532. ISI[000292579200007].
[WOS]. OI_0722-080411.
35. Phorboxazole Synthetic Studies: Design, Synthesis and Biological Evaluation of Phorboxazole A and Hemi-phorboxazole A related analogues. Smith, A.B., A.M.L. Hogan, Z.Q. Liu, T.M. Razler, R.M. Meis, B.I. Morinaka, and T.F. Molinski, Tetrahedron, 2011. 67(27-28): p. 5069-5078. ISI[000292721000012]. [WOS]. OI_0722-080411.
36. Biological Activity and Structure Dependent Properties of Cuprous iodide Complexes with Phenanthrolines and Water soluble tris (Aminomethyl) phosphanes. Starosta, R., K. Stokowa, M. Florek, J. Krol, A. Chwilkowska, J. Kulbacka, J. Saczko, J. Skala, and M. Jezowska-Bojczuk, Journal of Inorganic Biochemistry, 2011. 105(8): p. 1102-1108. ISI[000292851900014].
[WOS]. OI_0722-080411.
37. Antimicrobial Potential and Chemical Composition of Mentha piperita Oil in Liquid and Vapour Phase Against Food Spoiling Microorganisms. Tyagi, A.K. and A. MalikFood Control, 2011. 22(11): p. 1707-1714. ISI[000292710900002].
[WOS]. OI_0722-080411.
38. Novel Inhibitors of InhA Efficiently Kill Mycobacterium tuberculosis under Aerobic and Anaerobic Conditions. Vilcheze, C., A.D. Baughn, J. Tufariello, L.W. Leung, M. Kuo, C.F. Basler, D. Alland, J.C. Sacchettini, J.S. Freundlich, and W.R. Jacobs, Antimicrobial Agents and Chemotherapy, 2011. 55(8): p. 3889-3898. ISI[000292733800031].
[WOS]. OI_0722-080411.
39. Synthesis and Antituberculosis Activity of Derivatives of the Diterpenoid isosteviol with Azine, Hydrazide, and Hydrazone Moieties. Garifullin, B.F., I.Y. Strobykina, G.G. Mordovskoi, V.F. Mironov, and V.E. Kataev, Chemistry of Natural Compounds, 2011. 47(1): p. 55-58. ISI[000292636200013].
[WOS]. OI_0722-080411.
40. Antimicrobial Activity of Two Essential Oils.Mickiene, R., B. Bakutis, and V. Baliukoniene, Annals of Agricultural and Environmental Medicine, 2011. 18(1): p. 139-144. ISI[000292436800020].
[WOS]. OI_0722-080411.
41. Silver Enhances the In vitro Antifungal Activity of the Saponin, CAY-1. De Lucca, A.J., S. Boue, T. Sien, T.E. Cleveland, and T.J. Walsh, Mycoses, 2011. 54(4): p. E1-E9. ISI[000292501600001].
[WOS]. OI_0722-080411.